High-throughput in vitro assays
with dry AMD pathophysiology key features

Human iPSC-derived Retinal Pigment Epithelium AMD model
to improve the relevance and reproducibility of your R&D

High-throughput platform

Our high-content screening assays can test a large number of compounds in 96wp format.
Identify the most promising compounds before further downstream studies.

Blue light exposure

Use our iPSC-derived in vitro model assay
to improve the relevance of
your ophthalmology dry AMD R&D 
Screenable endpoint
Live/Dead in 96 wells plate

Trusted iPSC expert

Partnering Research Organization
since 2013
100% of our clients recommend Phenocell*
*Satisfaction survey performed on Dec 2019, on a representative sample of customers

Get in touch

We can get back to you by email
to discuss on how our model can be the right choice for your R&D:

Thank you! Your message has been received. We shall get back to you shortly.
Something went wrong while submitting the form.
Move your R&D forward
with our innovative, efficient and cost-effective bioassays and cell models
Get in touch